Access
To read this story in full you will need to login or make a payment (see right).
Technical Report
Nature Medicine 12, 852 - 855 (2006)
Published online: 25 June 2006 | Corrected online: 13 September 2006 | doi:10.1038/nm1437
There is an Erratum (October 2006) associated with this Technical Report.
Sensitive mutation detection in heterogeneous cancer specimens by massively parallel picoliter reactor sequencing
Roman K Thomas1,2,12, Elizabeth Nickerson3,12, Jan F Simons3,11,12, Pasi A Jänne1, Torstein Tengs1,2, Yuki Yuza1, Levi A Garraway1,2,4, Thomas LaFramboise1,2, Jeffrey C Lee1,2, Kinjal Shah1,2, Keith O'Neill2, Hidefumi Sasaki5, Neal Lindeman6, Kwok-Kin Wong1, Ana M Borras7, Edward J Gutmann8, Konstantin H Dragnev9, Ralph DeBiasi1,2, Tzu-Hsiu Chen1,2, Karen A Glatt1, Heidi Greulich1,2, Brian Desany3, Christine K Lubeski3, William Brockman2, Pablo Alvarez2, Stephen K Hutchison3, J H Leamon3, Michael T Ronan3, Gregory S Turenchalk3, Michael Egholm3, William R Sellers1,2, Jonathan M Rothberg3 & Matthew Meyerson1,2,10,11
Abstract
The sensitivity of conventional DNA sequencing in tumor biopsies is limited by stromal contamination and by genetic heterogeneity within the cancer. Here, we show that microreactor-based pyrosequencing can detect rare cancer-associated sequence variations by independent and parallel sampling of multiple representatives of a given DNA fragment. This technology can thereby facilitate accurate molecular diagnosis of heterogeneous cancer specimens and enable patient selection for targeted cancer therapies.
NOTE: In the version of this article initially published, it should have been acknowledged that Jan F. Simons, in addition to Roman K. Thomas and Elizabeth Nickerson, contributed equally to this work. The error has been corrected in the HTML and PDF versions of the article.
To read this story in full you will need to login or make a payment (see right).
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated.
RESEARCH
High-throughput oncogene mutation profiling in human cancerNature Genetics Letter (01 Mar 2007)
Genome sequencing in microfabricated high-density picolitre reactorsNature Article (15 Sep 2005)
BIBW2992, an irreversible EGFR/HER2 inhibitor highly effective in preclinical lung cancer modelsOncogene Original Article
